## Abstract A threeβway crossover study was performed to compare the bioavailability of a new pelletised doxycycline product administered either with food or without food and a reference product taken without food. Four different methods were used to calculate pharmacokinetic parameters from the d
Use of a power-consumption-controlled extruder in the development of pellet formulations
β Scribed by Peter Kleinebudde
- Publisher
- John Wiley and Sons
- Year
- 1995
- Tongue
- English
- Weight
- 717 KB
- Volume
- 84
- Category
- Article
- ISSN
- 0022-3549
No coin nor oath required. For personal study only.
β¦ Synopsis
Shape is an important characteristic of pellets that is highly influenced by the water content of the extrudate during spheronization. The power-consumption-controlled extruder (pcc-extruder) is an appropriate tool to adjust the required water content to yield round pellets. For this purpose, it is necessary to run the extruder at a specific level of power consumption. In the first part of the study, this approach was employed to screen different drugs as well as excipients to prove the concept of the pcc-extruder. Usually round pellets were obtained but a few formulations did not produce round pellets. In the second part of the study, the influence of screw speed and powder feed rate on the required level of power consumption was investigated. A correlation between the water content and the shape of pellets was evident. To account for screw speed, it was necessary to adjust net power consumption instead of total power consumption. The influence of the screw speed on water content of extrudate and consequently on the shape of pellets was not significant in the studied range. Variations of the powder feed rate affected both the water content and the shape of pellets. However, the water content was not only dependent on the level of net power consumption. The specific power is the ratio of net power consumption to extrusion rate, and it correlates well with water content and pellet shape. Using the specific power, it is possible to adjust the net power consumption in response to changes in powder feed rate.
π SIMILAR VOLUMES
Development of modified-release oral tablets of drug products usually requires release-modifying polymers at the level of above 50% of the total weight. This makes the development of high-dose products, especially with doses in the range of 750-1000 mg, difficult because the tablet size becomes unac
Development of a controlled-released formulation of chlorpheniramine maleate is described, using in vitro/in vivo correlates, according to a process that has been termed "biorelevant dissolution". The process begins with simulations using several possible input rates combined with known disposition
Laminar morphology of high-density polyethylene (HDPE)/ polyamide-6 (PA-6) blends was obtained, for the first time, in a co-rotating twin screw extruder. The morphology analysis in the interior of the adapter, which connects the extruder with a slit die, revealed that, under specific processing cond
Figure 4: Title is related to primary energy input instead of GHG emissions -the legend should read: Primary energy input of three illustrative pellet chains in Europe β’ Figures 4 and 5: Th e red legend bar 'Drying feedstock' is missing from the keys for both fi gures indicating the y axes 'Primary